These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 15574177
1. Fever as a precipitant of idiopathic ventricular fibrillation in patients with normal hearts. Pasquié JL, Sanders P, Hocini M, Hsu LF, Scavée C, Jais P, Takahashi Y, Rotter M, Sacher F, Victor J, Clémenty J, Haïssaguerre M. J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1271-6. PubMed ID: 15574177 [Abstract] [Full Text] [Related]
2. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease. Bode K, Hindricks G, Piorkowski C, Sommer P, Janousek J, Dagres N, Arya A. Pacing Clin Electrophysiol; 2008 Dec; 31(12):1585-91. PubMed ID: 19067811 [Abstract] [Full Text] [Related]
4. Sudden cardiac arrest associated with early repolarization. Haïssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, Pasquié JL, Nogami A, Babuty D, Yli-Mayry S, De Chillou C, Scanu P, Mabo P, Matsuo S, Probst V, Le Scouarnec S, Defaye P, Schlaepfer J, Rostock T, Lacroix D, Lamaison D, Lavergne T, Aizawa Y, Englund A, Anselme F, O'Neill M, Hocini M, Lim KT, Knecht S, Veenhuyzen GD, Bordachar P, Chauvin M, Jais P, Coureau G, Chene G, Klein GJ, Clémenty J. N Engl J Med; 2008 May 08; 358(19):2016-23. PubMed ID: 18463377 [Abstract] [Full Text] [Related]
5. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W, Kilicaslan F, Cummings J, Burkhardt JD, Bhargava M, Bash D, Brachmann J, Guenther J, Hao S, Beheiry S, Rossillo A, Raviele A, Themistoclakis S, Natale A. J Am Coll Cardiol; 2004 May 05; 43(9):1715-20. PubMed ID: 15120835 [Abstract] [Full Text] [Related]
6. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. Knecht S, Sacher F, Wright M, Hocini M, Nogami A, Arentz T, Petit B, Franck R, De Chillou C, Lamaison D, Farré J, Lavergne T, Verbeet T, Nault I, Matsuo S, Leroux L, Weerasooriya R, Cauchemez B, Lellouche N, Derval N, Narayan SM, Jaïs P, Clementy J, Haïssaguerre M. J Am Coll Cardiol; 2009 Aug 04; 54(6):522-8. PubMed ID: 19643313 [Abstract] [Full Text] [Related]
9. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
19. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F, Gimeno JR, Payá E, García-Alberola A, Pérez-Alvarez L, Fernández X, de la Morena G, Sogorb F, Castro-Beiras A, Valdés M, Martínez JG, Monserrat L. Rev Esp Cardiol; 2006 Jun 01; 59(6):537-44. PubMed ID: 16790196 [Abstract] [Full Text] [Related]